INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Cancer Trials Ireland
Cancer Trials Ireland
M.D. Anderson Cancer Center
Mayo Clinic
NYU Langone Health
Maastricht University Medical Center
Hoosier Cancer Research Network
Hoosier Cancer Research Network
Case Comprehensive Cancer Center
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut Cancerologie de l'Ouest
The Christie NHS Foundation Trust
University of Washington
Virginia Commonwealth University
University of Kentucky
Stanford University
National Cancer Institute (NCI)
Eli Lilly and Company